ACCPL
Start SIP
Invest Now
Start SIP in ACCPL
Performance
- Low
- ₹74
- High
- ₹74
- 52 Week Low
- ₹54
- 52 Week High
- ₹103
- Open Price₹74
- Previous Close₹77
- Volume15,600
- 50 DMA₹81.07
- 100 DMA₹75.80
- 200 DMA-
Investment Returns
- Over 1 Month -20.41%
- Over 3 Month + 25.21%
- Over 6 Month + 15.29%
- Over 1 Year -27.23%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12
- PEG Ratio
- -
- Market Cap Cr
- 82
- P/B Ratio
- 1.8
- Average True Range
- 4.12
- EPS
- 6.11
- Dividend Yield
- 0
- MACD Signal
- 0.78
- RSI
- 38.08
- MFI
- 27.73
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
Current Price
₹73.50
-3.85
(-4.98%)
- Bearish Moving Average 12
- Bullish Moving Average 2
- 20 Day
- ₹84.68
- 50 Day
- ₹81.07
- 100 Day
- ₹75.80
- 200 Day
- -
Resistance and Support
78.05
- R3 80.85
- R2 80.15
- R1 78.75
- S1 76.65
- S2 75.95
- S3 74.55
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-06-10 | Audited Results & Others | To consider Other business matters. |
Accretion Pharmaceuticals F&O
About Accretion Pharmaceuticals
- NSE Symbol
- ACCPL
- BSE Symbol
- Managing Director
- Mr. Vivek Ashok Kumar Patel
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹73 As on 12 January, 2026 | 12:59
The Market Cap of Accretion Pharmaceuticals is ₹81.7 Cr As on 12 January, 2026 | 12:59
The P/E ratio of Accretion Pharmaceuticals is 12 As on 12 January, 2026 | 12:59
The PB ratio of Accretion Pharmaceuticals is 1.8 As on 12 January, 2026 | 12:59
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.